Repligen Corporation logo

Repligen Corporation

NASDAQ:RGEN

Overview | Financials
Company Name Repligen Corporation
Symbol RGEN
Currency USD
Price 147.07
Market Cap 8,236,875,955
Dividend Yield 0%
52-week-range 110.45 - 211.13
Industry Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Anthony J. Hunt
Website https://www.repligen.com

An error occurred while fetching data.

About Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography

Related Stocks

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

25.55 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

120.17 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

59.11 USD

Bruker Corporation logo

Bruker Corporation

BRKR

64.01 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

9.05 USD

NovoCure Limited logo

NovoCure Limited

NVCR

16.88 USD

Masimo Corporation logo

Masimo Corporation

MASI

111.53 USD

Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

JAZZ

107.14 USD

Financials

Numbers are in millions USD

Numbers are in millions USD